Knowledge (XXG)

Daria Hazuda

Source đź“ť

215:
to develop a new assay, which involved viral "donor DNA" mimics attached to the wells of a plate and labeled target DNA. Integrase strand transfer activity was measured by the labeled DNA getting stuck to the well after unreacted products were washed off. The assay worked, but it was incompatible with the available robots, so she and two assistants, over several months in 1999, had to pipet over 250,000 compounds by hand.
174:. Additionally, as Chief Scientific Officer of the Merck Research Laboratory Cambridge Exploratory Science Center she oversees research on interactions between the human microbiome and immunity. She previously served as Global Director of Scientific Affairs for Antivirals in Merck's division of Global Human Health, as well as co-site head of basic research for the Merck West Point research facility. 214:
Hazuda was not the first or only scientist working to develop integrase inhibitors. However, whereas most scientists were focused on blocking the early steps (and were not having much success), Hazuda focused on the later, strand transfer, step. In order to screen for inhibitors of this step, she had
165:
Hazuda joined Merck in 1989, where she started as a Senior Research Biochemist in the antiviral research group. She was initially assigned to work on influenza, but she asked to be switched to HIV research. She continues to oversee Merck's HIV research, which includes the development of long-acting
210:
which has several sequential functions: it binds to the ends of the viral DNA and processes them by removing a couple of nucleotides from each end. It then aids the 3'OH of the viral DNA in attacking the phosphodiester backbone of the host DNA, cleaving it at an integration site and attaching the
246:
presented her with the Distinguished Research Career Award. In 2017, she was part of a team of chemists awarded the “Heroes of Chemistry” award from the American Chemical Society for the development of the HCV combination therapy Elbasvir/Grazoprevir. She was Elected as a Fellow to the
177:
Hazuda is on the editorial board of the American Chemical Society Journal on Anti-infectives Research and the Journal of Viral Eradication. She previously served on the scientific advisory boards of and the Center for Aids Research (CFAR) of
109:). Her lab also determined these inhibitors' mechanism of action and ways the virus could develop resistance to them. Hazuda has also performed extensive research and led the development of antivirals for Hepatitis C Virus (HCV) including 226:(Isentress) was found - it was originally developed as a potential hepatitis C polymerase inhibitor which was found to be ineffective for that purpose. It was approved by the FDA for use in patients with HIV in October 2007. 590:. "Class salutatorian Daria J. Hazuda used her address to caution the community against allowing overcrowding expected at the school next year to result in any subsequent lowering of academic standards at the school." 222:(InSTI), binding to viral DNA-bound integrase, chelating the active site magnesium ions, and thereby preventing the complex from binding to cellular DNA. Through a collaboration with Merck researchers in Rome, 133:. Her father was an engineer and her mother worked in the regulatory-compliance division of Janssen Pharmaceutica (now a part of Johnson & Johnson). She graduated in 1977 as the salutatorian at 772:
Espeseth, Amy S.; Felock, Peter; Wolfe, Abigail; Witmer, Marc; Grobler, Jay; Anthony, Neville; Egbertson, Melissa; Melamed, Jeffrey Y.; Young, Steve; Hamill, Terence; Cole, James L. (2000-10-10).
310:
Espeseth, Amy S.; Felock, Peter; Wolfe, Abigail; Witmer, Marc; Grobler, Jay; Anthony, Neville; Egbertson, Melissa; Melamed, Jeffrey Y.; Young, Steve; Hamill, Terence; Cole, James L. (2000-10-10).
166:
antiretrovirals. She has also been instrumental in the development of antiviral treatments for Hepatitis C Virus (HCV), leading the development of antivirals for Hepatitis C Virus (HCV) including
839:
Grobler, Jay A.; Stillmock, Kara; Hu, Binghua; Witmer, Marc; Felock, Peter; Espeseth, Amy S.; Wolfe, Abigail; Egbertson, Melissa; Bourgeois, Michele; Melamed, Jeffrey; Wai, John S. (2002-05-14).
371:
Grobler, Jay A.; Stillmock, Kara; Hu, Binghua; Witmer, Marc; Felock, Peter; Espeseth, Amy S.; Wolfe, Abigail; Egbertson, Melissa; Bourgeois, Michele; Melamed, Jeffrey; Wai, John S. (2002-05-14).
206:
As a retrovirus, HIV has an RNA genome which it reverse transcribes into a double-stranded DNA copy, which it then inserts into the host cell's genome. This insertion is done by an enzyme called
261:
Hazuda, Daria J.; Felock, Peter; Witmer, Marc; Wolfe, Abigail; Stillmock, Kara; Grobler, Jay A.; Espeseth, Amy; Gabryelski, Lori; Schleif, William; Blau, Carol; Miller, Michael D. (2000-01-28).
234:
Hazuda has received the Bernie Field Lecture Award and the David Barry DART (Development of Antiretroviral Therapies) Achievement Award. The integrase inhibitor she led the development of,
953: 948: 218:
In 2000, her group published two key papers showing effective integrase inhibitors could be made. She demonstrated that the inhibitors she had identified acted as
36: 195: 968: 943: 179: 134: 993: 194:
Basic Sciences Board of Scientific Counselors, and the Scientific Program Advisory Council of the American Foundation for Aids Research (
963: 933: 908:"Inside Perspectives on the Discovery of the Hep C Combo Therapy Elbasvir/Grazoprevir | WuXi XPress: for WuXi news and R&D insights" 907: 219: 94: 958: 841:"Diketo acid inhibitor mechanism and HIV-1 integrase: Implications for metal binding in the active site of phosphotransferase enzymes" 373:"Diketo acid inhibitor mechanism and HIV-1 integrase: Implications for metal binding in the active site of phosphotransferase enzymes" 248: 130: 141:, but fell in love with research during a part-time job in a lab and decided to go into drug discovery. She earned got a B.S. from 774:"HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase" 312:"HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase" 743: 983: 978: 973: 187: 500: 242:), was awarded the Prix Galien prize in 2008. She was awarded the Italian Premio Galeno Award for this work. In 2019 she 610: 98: 577: 191: 150: 154: 938: 554: 190:
Aids Research Advisory Committee (ARAC). She is a member of The Forum for HCV Collaborative Research, the
146: 744:"Merck's New Integrase Inhibitor Isentress & Daria Hazuda: The long path to developing an AIDS drug" 243: 138: 988: 852: 785: 384: 323: 274: 183: 668: 142: 32: 263:"Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells" 888: 870: 821: 803: 725: 707: 660: 582: 420: 402: 359: 341: 298: 290: 878: 860: 811: 793: 715: 699: 650: 410: 392: 349: 331: 282: 262: 524: 856: 789: 388: 327: 278: 751: 720: 687: 587: 465: 118: 75: 883: 840: 415: 372: 927: 816: 773: 672: 354: 311: 211:
viral DNA in a step called strand transfer. Cellular enzymes then fill in the gaps.
65: 97:(InSTIs) and leading the development of the first HIV integrase inhibitor to gain 286: 239: 235: 223: 171: 121:
and Chief Scientific Officer of their MRL Cambridge Exploratory Science Center.
117:. She currently serves as Vice President for Infectious Diseases Discovery for 114: 106: 102: 655: 638: 874: 807: 711: 406: 345: 294: 207: 892: 865: 825: 798: 729: 664: 501:"2018 Distinguished Research Career Award | College of Veterinary Medicine" 424: 397: 363: 336: 302: 167: 110: 61: 703: 555:"N.J. native's research lead to Merck's groundbreaking HIV drug" 91: 153:. She then did a post-doctoral research fellowship at 71: 57: 42: 28: 21: 578:"Spirit the key to goals, Hillsborough grads told" 46:developing first approved HIV integrase inhibitor 90:is a biochemist known for discovering the first 845:Proceedings of the National Academy of Sciences 778:Proceedings of the National Academy of Sciences 377:Proceedings of the National Academy of Sciences 316:Proceedings of the National Academy of Sciences 137:. She initially pursued a premedical degree at 954:People from Hillsborough Township, New Jersey 145:, followed by a PhD in biochemistry from the 8: 949:Hillsborough High School (New Jersey) alumni 586:, June 17, 1977. Accessed May 4, 2022, via 147:State University of New York at Stony Brook 37:State University of New York at Stony Brook 18: 882: 864: 815: 797: 719: 654: 553:Services, Star-Ledger Wire (2009-11-07). 414: 396: 353: 335: 157:in the department of Molecular Genetics. 688:"The molecular biology of HIV integrase" 438: 202:Research on HIV-1 integrase inhibitors 7: 632: 630: 604: 602: 600: 598: 596: 548: 546: 544: 495: 493: 491: 489: 487: 485: 460: 458: 456: 454: 452: 450: 448: 446: 444: 442: 95:Integrase Strand Transfer Inhibitors 220:Integrase Strand Transfer Inhibitor 14: 131:Hillsborough Township, New Jersey 249:American Academy of Microbiology 1: 969:Stony Brook University alumni 643:Nature Reviews Drug Discovery 637:Mullard, Asher (2019-05-31). 944:Georgetown University alumni 287:10.1126/science.287.5453.646 994:21st-century American women 1010: 964:Scientists from New Jersey 934:American women biochemists 656:10.1038/d41573-019-00091-y 959:Rutgers University alumni 149:, where she trained with 81: 50: 686:Craigie, Robert (2012). 525:"Meet Daria Hazuda, PhD" 155:Smith, Kline, and French 135:Hillsborough High School 125:Early life and education 866:10.1073/pnas.092056199 799:10.1073/pnas.200139397 611:"Merck's AIDS Triumph" 398:10.1073/pnas.092056199 337:10.1073/pnas.200139397 244:Ohio State University 139:Georgetown University 129:Hazuda was raised in 984:Antiretroviral drugs 979:HIV vaccine research 974:Integrase inhibitors 857:2002PNAS...99.6661G 790:2000PNAS...9711244E 784:(21): 11244–11249. 466:"Daria Hazuda, PhD" 389:2002PNAS...99.6661G 328:2000PNAS...9711244E 322:(21): 11244–11249. 279:2000Sci...287..646H 184:Gladstone Institute 161:Career and research 470:Virology Education 143:Rutgers University 33:Rutgers University 851:(10): 6661–6666. 704:10.2217/FVL.12.56 609:Herper, Matthew. 383:(10): 6661–6666. 273:(5453): 646–650. 230:Honors and awards 85: 84: 52:Scientific career 1001: 918: 917: 915: 914: 903: 897: 896: 886: 868: 836: 830: 829: 819: 801: 769: 763: 762: 760: 759: 750:. Archived from 740: 734: 733: 723: 683: 677: 676: 658: 634: 625: 624: 622: 621: 606: 591: 575: 569: 568: 566: 565: 550: 539: 538: 536: 535: 521: 515: 514: 512: 511: 497: 480: 479: 477: 476: 462: 428: 418: 400: 367: 357: 339: 306: 19: 1009: 1008: 1004: 1003: 1002: 1000: 999: 998: 924: 923: 922: 921: 912: 910: 905: 904: 900: 838: 837: 833: 771: 770: 766: 757: 755: 742: 741: 737: 692:Future Virology 685: 684: 680: 636: 635: 628: 619: 617: 608: 607: 594: 576: 572: 563: 561: 552: 551: 542: 533: 531: 523: 522: 518: 509: 507: 499: 498: 483: 474: 472: 464: 463: 440: 435: 370: 309: 260: 257: 232: 204: 186:as well as the 163: 127: 29:Alma mater 24: 17: 12: 11: 5: 1007: 1005: 997: 996: 991: 986: 981: 976: 971: 966: 961: 956: 951: 946: 941: 936: 926: 925: 920: 919: 898: 831: 764: 735: 698:(7): 679–686. 678: 649:(7): 492–493. 639:"Daria Hazuda" 626: 592: 588:Newspapers.com 570: 540: 516: 481: 437: 436: 434: 431: 430: 429: 368: 307: 256: 253: 231: 228: 203: 200: 162: 159: 126: 123: 88:Daria J Hazuda 83: 82: 79: 78: 73: 69: 68: 59: 55: 54: 48: 47: 44: 43:Known for 40: 39: 30: 26: 25: 22: 15: 13: 10: 9: 6: 4: 3: 2: 1006: 995: 992: 990: 987: 985: 982: 980: 977: 975: 972: 970: 967: 965: 962: 960: 957: 955: 952: 950: 947: 945: 942: 940: 939:Living people 937: 935: 932: 931: 929: 909: 902: 899: 894: 890: 885: 880: 876: 872: 867: 862: 858: 854: 850: 846: 842: 835: 832: 827: 823: 818: 813: 809: 805: 800: 795: 791: 787: 783: 779: 775: 768: 765: 754:on 2017-01-31 753: 749: 748:www.natap.org 745: 739: 736: 731: 727: 722: 717: 713: 709: 705: 701: 697: 693: 689: 682: 679: 674: 670: 666: 662: 657: 652: 648: 644: 640: 633: 631: 627: 616: 612: 605: 603: 601: 599: 597: 593: 589: 585: 584: 583:The Home News 579: 574: 571: 560: 556: 549: 547: 545: 541: 530: 526: 520: 517: 506: 502: 496: 494: 492: 490: 488: 486: 482: 471: 467: 461: 459: 457: 455: 453: 451: 449: 447: 445: 443: 439: 432: 426: 422: 417: 412: 408: 404: 399: 394: 390: 386: 382: 378: 374: 369: 365: 361: 356: 351: 347: 343: 338: 333: 329: 325: 321: 317: 313: 308: 304: 300: 296: 292: 288: 284: 280: 276: 272: 268: 264: 259: 258: 254: 252: 250: 245: 241: 237: 229: 227: 225: 221: 216: 212: 209: 201: 199: 197: 193: 189: 185: 181: 175: 173: 169: 160: 158: 156: 152: 148: 144: 140: 136: 132: 124: 122: 120: 116: 112: 108: 104: 100: 96: 93: 89: 80: 77: 74: 70: 67: 63: 60: 56: 53: 49: 45: 41: 38: 34: 31: 27: 20: 911:. Retrieved 901: 848: 844: 834: 781: 777: 767: 756:. Retrieved 752:the original 747: 738: 695: 691: 681: 646: 642: 618:. Retrieved 614: 581: 573: 562:. Retrieved 558: 532:. Retrieved 528: 519: 508:. Retrieved 504: 473:. Retrieved 469: 380: 376: 319: 315: 270: 266: 233: 217: 213: 205: 176: 164: 151:Cheng-Wen Wu 128: 87: 86: 72:Institutions 66:Biochemistry 51: 23:Daria Hazuda 989:Hepatitis C 505:vet.osu.edu 240:raltegravir 224:raltegravir 172:Grazoprevir 115:Grazoprevir 107:raltegravir 928:Categories 913:2020-08-01 758:2020-08-01 620:2020-08-01 564:2020-08-01 534:2020-08-01 510:2020-08-01 475:2020-08-01 433:References 255:Key papers 101:approval, 16:Biochemist 875:0027-8424 808:0027-8424 712:1746-0794 673:195773864 529:merck.com 407:0027-8424 346:0027-8424 295:0036-8075 251:in 2010. 236:Isentress 208:integrase 103:Isentress 893:11997448 826:11016953 730:23024700 665:31267069 425:11997448 364:11016953 303:10649997 182:and the 168:Elbasvir 111:Elbasvir 906:yinan. 853:Bibcode 786:Bibcode 721:3458710 385:Bibcode 324:Bibcode 275:Bibcode 267:Science 62:Biology 891:  884:124459 881:  873:  824:  814:  806:  728:  718:  710:  671:  663:  615:Forbes 423:  416:124459 413:  405:  362:  352:  344:  301:  293:  58:Fields 817:17185 669:S2CID 355:17185 196:AMFAR 119:Merck 76:Merck 889:PMID 871:ISSN 822:PMID 804:ISSN 726:PMID 708:ISSN 661:PMID 421:PMID 403:ISSN 360:PMID 342:ISSN 299:PMID 291:ISSN 180:UCLA 170:and 113:and 879:PMC 861:doi 812:PMC 794:doi 716:PMC 700:doi 651:doi 411:PMC 393:doi 350:PMC 332:doi 283:doi 271:287 198:). 192:NCI 188:NIH 99:FDA 92:HIV 930:: 887:. 877:. 869:. 859:. 849:99 847:. 843:. 820:. 810:. 802:. 792:. 782:97 780:. 776:. 746:. 724:. 714:. 706:. 694:. 690:. 667:. 659:. 647:18 645:. 641:. 629:^ 613:. 595:^ 580:, 559:nj 557:. 543:^ 527:. 503:. 484:^ 468:. 441:^ 419:. 409:. 401:. 391:. 381:99 379:. 375:. 358:. 348:. 340:. 330:. 320:97 318:. 314:. 297:. 289:. 281:. 269:. 265:. 64:, 35:, 916:. 895:. 863:: 855:: 828:. 796:: 788:: 761:. 732:. 702:: 696:7 675:. 653:: 623:. 567:. 537:. 513:. 478:. 427:. 395:: 387:: 366:. 334:: 326:: 305:. 285:: 277:: 238:( 105:(

Index

Rutgers University
State University of New York at Stony Brook
Biology
Biochemistry
Merck
HIV
Integrase Strand Transfer Inhibitors
FDA
Isentress
raltegravir
Elbasvir
Grazoprevir
Merck
Hillsborough Township, New Jersey
Hillsborough High School
Georgetown University
Rutgers University
State University of New York at Stony Brook
Cheng-Wen Wu
Smith, Kline, and French
Elbasvir
Grazoprevir
UCLA
Gladstone Institute
NIH
NCI
AMFAR
integrase
Integrase Strand Transfer Inhibitor
raltegravir

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑